Tamoxifen is a selective estrogen receptor (ER) regulator which competes with estradiol for the ER and forms a stable complex with it, thereby inhibiting the growth and development of cancer cells (Jordan and Dowse, 1976). The gene discussed is ESR1; the disease is cancer.